MetaCap

Emergent BioSolutions Statistics

NYSE: EBSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.05-0.10 (-1.94%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Emergent BioSolutions by the numbers

Emergent BioSolutions has a market capitalization of $259.6 million based on 51.42M shares outstanding. With trailing EPS of $-5.00, Emergent BioSolutions is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.7% below its 50-day average and 33.4% below its 200-day average.

Average daily trading volume is 1.11M shares, or about $5.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

EBS valuation vs. peer median

EBS compared with the median of 8 peer companies
MetricEBSPeer medianDifference
Market cap$259.65M$258.72M+0%
Avg. volume1.11M423.72K+162%

Peer median across 8 companies: ALT, PRLD, VCRE, QTTB, GALT, TTRX, LFCR, RLMD.

Valuation

Market cap
$259.65M
Price / sales (latest FY)
0.35
EPS (TTM)
$-5.00

Price and trading

Previous close
5.15
Open
5.08
Day range
4.98 – 5.24
52-week range
4.36 – 14.06
52-week change
-49.70%
Beta
—
Volume
1.39M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
259.65M
Forward Pe
4.83
Eps
-5.00
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
14.06
Week52 Low
4.36
Avg Volume
1.11M
Shares Outstanding
51.42M
Ma50
6.45
Ma200
7.59
Earnings Date
Nov 2, 2026
Pct From52w High
-64.08%
Pct From52w Low
15.83%

Related